Hindustan Syringes & Medical Devices Ltd
Next 500 2021
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Next 500 India
#423(2021)
#423(2021)
Financial Data 2024
Revenue
816
(INR Cr)
Net Operating Income
787
(INR Cr)
Assets
964
(INR Cr)
Profit
60
(INR Cr)
Net Worth
957
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 816 -6.1% | 868 -6.6% | 930 33.9% | 695 2.0% | 681 8.0% | 631 8.3% | 582 -1.6% | 592 9.7% | 540 -4.0% | 562 7.1% | 525 11.9% | 469 3.2% | 454 9.8% | 414 9.0% | 380 7.0% | 355 - |
| Net Operating Income (INR Cr) | 787 -6.57% | 842 -5.80% | 894 40.83% | 635 0.00% | 645 6.78% | 604 1.30% | 597 7.30% | 556 5.41% | 527 -0.20% | 529 5.89% | 499 12.30% | 444 5.61% | 421 4.74% | 402 10.05% | 365 3.42% | 353 12.69% |
| Profit (INR Cr) | 60 18.5% | 50 -38.5% | 82 -0.5% | 82 -11.4% | 93 68.3% | 55 1.6% | 54 19.9% | 45 12.5% | 40 44.2% | 28 -24.3% | 37 -8.5% | 40 -1.4% | 41 88.0% | 22 -52.0% | 45 13.4% | 40 - |
| Assets (INR Cr) | 964 6.0% | 910 6.3% | 856 10.8% | 772 12.8% | 685 10.3% | 621 8.0% | 575 8.5% | 530 10.1% | 481 6.9% | 450 -0.9% | 454 11.1% | 409 8.4% | 378 9.3% | 345 7.3% | 322 14.5% | 281 - |
| Net Worth (INR Cr) | 957 6.6% | 898 5.7% | 849 10.7% | 767 0.0% | 681 10.0% | 619 8.1% | 573 8.5% | 528 10.3% | 479 7.0% | 447 2.9% | 435 6.9% | 407 8.4% | 375 9.4% | 343 6.5% | 322 14.5% | 281 14.5% |
| Employee Cost (INR Cr) | 139 6.2% | 131 2.7% | 128 19.3% | 107 6.7% | 100 17.8% | 85 5.2% | 81 8.5% | 75 9.6% | 68 14.4% | 60 13.0% | 53 12.8% | 47 6.0% | 44 26.6% | 35 -1.1% | 35 41.6% | 25 - |
| Interest Cost (INR Cr) | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 1 |
| Cash & Bank Balance (INR Cr) | 29 | 25 | 19 | 19 | 24 | 6 | 11 | 8 | 5 | 9 | 6 | 10 | 8 | 10 | 6 | 14 |
| Total Debt (INR Cr) | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 0 | 0 | 17 | 0 | 0 | 0 | 0 | 0 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 7.3% | 5.8% | 8.8% | 11.9% | 13.6% | 8.8% | 9.3% | 7.7% | 7.5% | 5.0% | 7.0% | 8.6% | 9.0% | 5.3% | 11.9% | 11.3% |
| Profit As % Of Assets | 6.2% | 5.5% | 9.6% | 10.7% | 13.6% | 8.9% | 9.5% | 8.6% | 8.4% | 6.2% | 8.1% | 9.9% | 10.8% | 6.3% | 14.1% | 14.2% |
| Profit As % Of Networth | 6.2% | 5.6% | 9.6% | 10.7% | 13.6% | 8.9% | 9.5% | 8.6% | 8.4% | 6.3% | 8.5% | 9.9% | 10.9% | 6.3% | 14.1% | 14.2% |
| Interest Cost to EBITDA % | 1.6% | 2.0% | 0.9% | 1.3% | 0.9% | 1.1% | 1.1% | 1.0% | 0.9% | 2.2% | 2.0% | 1.7% | 1.3% | - | 0.3% | 1.1% |
| Debt to Equity Ratio | - | - | - | - | - | 0.00 | 0.00 | 0.00 | - | - | 0.04 | - | - | - | - | - |
| RONW | 6.4% | 5.8% | 8.2% | 5.5% | 14.3% | 7.7% | 8.8% | 9.0% | 8.7% | 6.3% | 6.3% | 8.5% | 9.8% | 6.3% | 14.1% | 15.2% |
| ROCE | 8.9% | 8.0% | 11.5% | 8.2% | 17.8% | 11.3% | 13.0% | 13.5% | 11.4% | 8.8% | 8.6% | 11.4% | 13.2% | 10.0% | 20.1% | 22.3% |